Fundraising Fox3B Future Health Fund — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Gain Therapeutics is a biotechnology company that develops small molecule drugs targeting allosteric binding sites on disease-related proteins, using its computational Magellan platform to discover compounds that stabilize or destabilize proteins to treat central nervous system disorders, lysosomal storage diseases, metabolic disorders, and oncology; its lead candidate GT-02287 is in Phase 1b testing for Parkinson's disease.
AI & Machine LearningBiotechDeep TechDigital HealthMedical DevicesBethesda, US
Gene Mack(President, Chief Executive Officer and Director)in
BoardMarianne Bjordal(Director)inLorenzo Leoni(Director)inKhalid Islam(Director)Jeffrey Riley(Director)Eric I. Richman(Executive Officer, Director)
Co-investorsTiVenture SAAllele Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.